Male polycystic ovary syndrome equivalent: A response to Di Guardo et al

Rossella Cannarella; Sandro La Vignera; Federica Barbagallo; Rosita A Condorelli; Aldo E Calogero

doi:10.1016/j.mehy.2020.109601

Male polycystic ovary syndrome equivalent: A response to Di Guardo et al

Med Hypotheses. 2020 Apr:137:109601. doi: 10.1016/j.mehy.2020.109601. Epub 2020 Jan 25.

Authors

Rossella Cannarella¹, Sandro La Vignera¹, Federica Barbagallo¹, Rosita A Condorelli¹, Aldo E Calogero²

Affiliations

¹ Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
² Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. Electronic address: acaloger@unict.it.

PMID: 32006919
DOI: 10.1016/j.mehy.2020.109601

Abstract

We have read the recent article by Di Guardo and colleagues on the male polycystic ovary syndrome (PCOS) equivalent and we would like to further highlight some key-points concerning mainly the male PCOS equivalent definition, the diagnostic criteria, gender-related serum testosterone difference and fertility.

Keywords: Fertility; Male PCOS equivalent; Male Polycystic ovary syndrome equivalent; Testosterone.

Publication types

Letter

MeSH terms

Female
Fertility
Humans
Male
Polycystic Ovary Syndrome* / diagnosis
Testosterone

Substances

Testosterone